Sign in
4

Changes in Ownership

Ultragenyx Pharmaceutical Inc. Filed Acc 0000950170-24-081302

Director sold 584 shares at $40.98 ($23,932)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Sanders Corazon (Corsee) D. Director 2024-07-02 Sale 10b5-1 −584 $40.98 $23,932 12,009 D: show line 1 in the form
Open-market sales · 584 sh · avg $40.98 · $23,932
Loading xslF345X05/ownership.xml…